Evidence map›Paper›PMID 34166365›Full record

ArticlePLoS computational biology2021

PHENSIM: Phenotype Simulator.

Salvatore Alaimo, Rosaria Valentina Rapicavoli, Gioacchino P Marceca, Alessandro La Ferlita, Oksana B Serebrennikova, Philip N Tsichlis, Bud Mishra, Alfredo Pulvirenti, Alfredo Ferro

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Pathway Analysis for Cancer Research and Precision Oncology Applications.Advances in experimental medicine and biology · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Salvatore AlaimoBioinformatics Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.ORCID 0000-0003-4825-7617
Rosaria Valentina RapicavoliBioinformatics Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Gioacchino P MarcecaBioinformatics Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Alessandro La FerlitaBioinformatics Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Oksana B SerebrennikovaMolecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts, United States of America.
Philip N TsichlisDepartment of Cancer Biology and Genetics and the James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, United States of America.ORCID 0000-0002-5300-0448
Bud MishraDepartment of Computer Science, Courant Institute of Mathematical Sciences, New York University, New York, New York, United States of America.
Alfredo PulvirentiBioinformatics Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Alfredo FerroBioinformatics Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.ORCID 0000-0002-9431-5788
University of Catania · ITCourant Institute of Mathematical Sciences · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USTufts Medical Center · US

Funding

Topology of Cancer Evolution and HeterogeneityU54CA193313 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IAVARONE, ANTONIO, RABADAN, RAUL · 2015 to 2020
$10.4M
NCI NIH HHS U54 CA193313
6 · The paper itself

Abstract

Despite the unprecedented growth in our understanding of cell biology, it still remains challenging to connect it to experimental data obtained with cells and tissues' physiopathological status under precise circumstances. This knowledge gap often results in difficulties in designing validation experiments, which are usually labor-intensive, expensive to perform, and hard to interpret. Here we propose PHENSIM, a computational tool using a systems biology approach to simulate how cell phenotypes are affected by the activation/inhibition of one or multiple biomolecules, and it does so by exploiting signaling pathways. Our tool's applications include predicting the outcome of drug administration, knockdown experiments, gene transduction, and exposure to exosomal cargo. Importantly, PHENSIM enables the user to make inferences on well-defined cell lines and includes pathway maps from three different model organisms. To assess our approach's reliability, we built a benchmark from transcriptomics data gathered from NCBI GEO and performed four case studies on known biological experiments. Our results show high prediction accuracy, thus highlighting the capabilities of this methodology. PHENSIM standalone Java application is available at https://github.com/alaimos/phensim, along with all data and source codes for benchmarking. A web-based user interface is accessible at https://phensim.tech/.

Indexed as

AlgorithmsCell Physiological PhenomenaPhenotypeSoftwareAntineoplastic AgentsBenchmarkingCell BiologyCell LineCell Line, TumorComputational BiologyComputer SimulationFemaleGene Expression ProfilingHumansMAP Kinase Kinase KinasesMetforminAntineoplastic AgentsMAP3K8 protein, humanMAP Kinase Kinase KinasesMetforminProto-Oncogene ProteinsTumor Necrosis Factor-alpha

Identifiers

PMID34166365
PMCPMC8224893
OpenAlexW3177246609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.